← Back to All Filings

FONAR ($FONR) Q1 Earnings: Profit Down, Going-Private Talks Continue

High SignificanceNovember 12, 2025 at 2:35:05 PM EST

FONAR CORP

$FONR8-KCIK: 0000355019

Subscribe to track FONR

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

FONAR ($FONR) Q1 Earnings: Profit Down, Going-Private Talks Continue

Company: FONAR CORP (FONR) Form: 8-K | Filed: 2025/11/12 Significance: High

Event: Q1 Fiscal 2026 Earnings Report & Corporate Update

Key Financials: • Revenue: $26.0M (+4% YoY) • Net Income: $2.7M (-33% YoY) • Diluted EPS: $0.34 (-26% YoY)

Key Insight: FONAR reported mixed Q1 results with revenue growth but a significant drop in profitability. The company also provided an update on the ongoing negotiations for a management-led buyout proposal, which was first announced in July 2025. The stock repurchase plan remains suspended pending the outcome of these talks.

Market Context: The earnings miss on profitability could pressure the stock, but the ongoing buyout discussion may provide a potential price floor for shareholders.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: FONAR CORP (FONR)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: FONAR CORP reported mixed Q1 Fiscal 2026 results, with a 4% increase in revenue but a 33% decrease in net income. The earnings report is coupled with a significant corporate update regarding ongoing negotiations for a management-led proposal to take the company private.
  • Market Impact: The decline in profitability is a bearish signal, but the potential for a buyout could create price support and speculative interest.

Company Information

FieldValue
CompanyFONAR CORP
Ticker SymbolFONR
CIK0000355019
IndustryElectromedical & Electrotherapeutic Apparatus

Insider Information

FieldValue
NameNot Applicable (Company Filing)
CIKNot Applicable
Title/PositionNot Applicable
RelationshipNot Applicable

Transaction Details

This Form 8-K is a current report detailing the company's quarterly financial results and providing a corporate update. It does not report a specific insider transaction.

FieldValue
Form Type8-K
Earliest Event Date2025-11-10
Transaction CodeNot Applicable
Security TypeNot Applicable
Shares InvolvedNot Applicable
Price Per ShareNot Applicable
Total ValueNot Applicable
Shares Owned AfterNot Applicable
Ownership TypeNot Applicable

Financial Impact Assessment

Impact Evaluation

  • Earnings Performance: The company's revenue grew to $26.0 million, up 4% year-over-year. However, this was offset by a 33% increase in Selling, General & Administrative (SG&A) expenses, leading to a 30% decrease in Income from Operations and a 33% drop in Net Income. Diluted EPS fell to $0.34 from $0.46 in the prior-year quarter.
  • Going-Private Proposal: The filing confirms that negotiations are still active regarding the non-binding proposal from CEO Timothy Damadian and COO Luciano Bonanni to acquire all outstanding shares. The uncertainty of this transaction is a major factor for the stock.
  • Stock Repurchase Suspension: The company has suspended its stock repurchase plan, which was established in September 2022, in light of the ongoing buyout negotiations. This removes a source of buying pressure from the market.
  • Market Cap Context: With a market cap of only $90 million, FONAR is a micro-cap company. The reported quarterly net income of $2.7 million is substantial relative to its valuation, but the decline in profitability is a significant concern for investors.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The negative news of declining profitability is counterbalanced by the positive potential of a buyout premium from the management-led going-private transaction. This creates a complex scenario where the stock price may be caught between poor fundamental performance and M&A speculation.

Volume & Sentiment

  • Expected Volume Impact: Increased trading volume is likely as investors digest the mixed earnings and the update on the buyout talks.
  • Sentiment Indicator: Neutral. The market sentiment is split between the bearish signal from the earnings miss and the potentially bullish outcome of a successful buyout.

Investment Insights

Positive Market Indicators

  • Continued top-line revenue growth.
  • An active, ongoing negotiation for a going-private transaction, which could result in a premium for current shareholders.
  • Strong balance sheet with a current ratio of 8.6 and total assets significantly exceeding total liabilities.

Risk Factors

  • Significant decline in operating and net income, indicating margin pressure or rising costs.
  • The going-private transaction is non-binding and may not be completed, which could lead to a sharp price drop if talks fail.
  • Suspension of the stock buyback program removes a catalyst for share price support.

Key Takeaways

  1. Profitability Under Pressure: While revenue is growing, the company's inability to control costs is severely impacting its bottom line.
  2. Buyout Wildcard: The primary driver for the stock in the near term is the outcome of the going-private negotiations, not its operational performance.
  3. Micro-Cap Volatility: As a micro-cap stock, FONR is subject to higher volatility, and the current situation with mixed earnings and buyout talks exacerbates this risk.

Additional Context

Transaction Notes

  • The filing's main purpose is to disclose the financial results for the quarter ended September 30, 2025, as required by SEC regulations.
  • The update on the buyout proposal from July 2025 indicates that a Special Committee of independent directors is still engaged in negotiations with the management group.
Topics:#SECFiling#Form8K#FONR#EarningsReport#QuarterlyResults#StockMarket#Investing#HealthcareTech#GoingPrivate#Buyout

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.